Atlas Wealth LLC - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 6 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Atlas Wealth LLC ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2023$2,249
-26.4%
26,6200.0%0.00%
-100.0%
Q2 2023$3,056
-30.4%
26,6200.0%0.00%0.0%
Q1 2023$4,392
+52.3%
26,6200.0%0.00%0.0%
Q4 2022$2,88326,6200.00%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q3 2023
NameSharesValueWeighting ↓
HOME FEDERAL BANK OF TENNESSEE 100,000$8,5000.00%
LEE DANNER & BASS INC 50,000$40.00%
LBMC INVESTMENT ADVISORS, LLC 22,000$1,7160.00%
Atlas Wealth LLC 26,620$2,2490.00%
ACADEMY CAPITAL MANAGEMENT INC/TX 20,000$1,6900.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders